This Report Provides:
- An Overview Of The Global Market For Treatments Of
Skin Diseases, Perhaps The Most Common Of Human Afflications
- Analyses Of Global Market Trends, With Data From
2011 And 2012, Estimates For 2013, And Projections Of Compound Annual Growth
Rates (Cagrs) Through 2018
- Focused Coverage Of Four Major Categories Of Skin
Disease Of Exceptional Medical And Commercial Significance: Dermatitis
(Allergic And Contact), Cancers (Including Melanoma), Immune Disorders
(Including Psoriasis), And Infections (Bacterial, Fungal And Viral)
- Topics Such As Skin Structure And Function,
Diseases Of The Skin, Current Treatment Options, And Unmet Clinical Needs
- Discussion Of The Evolution Of The Market,
Including The Rising Prevalence Of Some Skin Diseases, And New Diagnostic And
Treatment Options
- Examination Of The Global Market By Product
Categories, Such As Anti-Allergic Products, Antibacterials, Antifungals,
Antivirals, Immunotherapies, And Anticancers
- Comprehensive Company Profiles Of Major Players.
Report
Scope
Introduction
Study
Goals And Objectives
The Aim Of This Report Is To Provide Detailed
Market, Technology And Industry Analyses To Help Readers Quantify And Qualify
The Market For Drugs Used In The Treatment Of The Major Skin Diseases. Special
Emphasis Is Given To Ongoing Research Into Improved Treatment Modalities,
Especially Those Utilizing Biological Approaches. Important Trends Are Identified
And Sales Forecasts By Product Categories And Major Country Markets Are
Provided Through 2018; These Are Based On Epidemiological Data And Projections
Plus Information On R&D Trends And Their Likely Effects On Market Potential
On A Country-By-Country Basis.
Complete
Report Copy @ http://www.rnrmarketresearch.com/skin-disease-treatment-technologies-and-global-markets-market-report.html
Reasons
For Doing The Study
The Dermatology Market Is Facing A Period Of Change
After Several Years During Which It Was A Relatively Modest And Slow-Growing
Sector Within The Overall Pharmaceutical Environment. The Advent Of Innovative
Therapies For Some Skin Diseases Has Been A Stimulus For Renewed Interest In
This Market Among Major Pharma Companies. New Contenders In This Market Have
Emerged As Small To Medium-Size Companies Evolve Into Medium To Large Concerns
By A Process Of Serial Acquisitions. In This Environment There Is A Need For An
Up-To-Date And Comprehensive Appraisal Of The Dermatology Marketplace, With A
Review Of The Most Important Diseases, Portfolios And Pipelines.
Scope
Of Report
This Report Discusses The Implications Of The
Above-Mentioned Trends In The Context Of The Current Size And Growth Of The
Dermatology Market, Discussed Both In Global Terms And In Reference To The Most
Important National Markets. Long-Standing And Emerging Companies Are Discussed,
With Profiles Of Their Leaders And An Update On M&A Activity. Five-Year
Global Sales Forecasts Are Provided For Main Drug Categories, And Breakdowns
Are Provided For Several National Markets.
Market
Analyses And Forecasts
Market Figures Are Based On Revenues At The
Manufacturer Level And Are Projected At 2012 Dollar Value Without An Attempt To
Predict The Effect Of Inflation/Deflation. Therapeutic Categories Discussed
Include Dermatitis, Psoriasis, Acne, Lupus, Skin Infections (Bacterial, Fungal,
Viral) And Skin Cancers.
Request
a Sample Copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=99894
Methodology
Primary Research Includes Interviews With Leading
Individuals In Relevant Companies And Medical Associations; Primary Sources Of
Published Data Include Epidemiological And Economic Studies, Company Annual
Reports, Sec Filings And Government Publications. Secondary Sources Consist Of
Literature Searches, Industry Journals And Other Commercial Publications. Data
For Market Estimates And Forecasts Are Pooled From A Range Of Sources And Are
Critically Assessed By Bcc. In This Report, “Global” Is Defined As The Sum Of
The Following National Markets: U.S., Japan, The Leading Five Eu Markets
(Germany, France, Italy, Spain And U.K., Abbreviated To Eu5) And The Four Bric
Countries: Brazil, Russia, India And China. The Rest Of The World Is Thought To
Represent Not Much More Than 10% Of The Actual Global Total, And There Are Few
Or No Data For Most Of The Countries That Contribute To This Segment, So We
Have Left Them Out Of The Discussion.
Intended
Audience
This Report Is Designed To Satisfy The Information
Needs Of A Wide Variety Of Individuals Involved In The Dermatology Marketplace,
Including Company Senior Management Executives Seeking To Base Their Strategic
Decisions On The Best Available Information On Market Forces And Trends.
However, It Is Also Aimed At Managers And Executives In Marketing, Research,
Planning And Sales Departments Who Need Readable, Comprehensive And Up-To-Date
Background On The Marketplace In Which They Are Operating.
Order/Buy
a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99894
